BriaCell Therapeutics Corp. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BriaCell Therapeutics Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2021 to Q2 2023.
  • BriaCell Therapeutics Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending July 31, 2023 was $15.9M, a 31.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $15.9M +$3.79M +31.2% Jul 31, 2023 10-K 2023-10-25
Q2 2022 $12.1M +$3.77M +45% Jul 31, 2022 10-K 2023-10-25
Q2 2021 $8.36M Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.